We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
+$740M
Cap. Flow %
2.5%
Top 10 Hldgs %
36.41%
Holding
1,385
New
83
Increased
652
Reduced
368
Closed
52

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$163M
2
NOW icon
ServiceNow
NOW
+$139M
3
ELS icon
Equity Lifestyle Properties
ELS
+$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Top Sells

Rank Stock Value
1
KRMA
Global X Conscious Companies ETF
KRMA
+$130M
2
SUI icon
Sun Communities
SUI
+$123M
3
SBAC icon
SBA Communications
SBAC
+$108M
4
MAA icon
Mid-America Apartment Communities
MAA
+$77.2M
5
WELL icon
Welltower
WELL
+$73M

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
1126
Axsome Therapeutics
AXSM
$11.8B
$20K ﹤0.01%
165
-12
-7% -$1.35K
NUVL
1127
DELISTED
Nuvalent
NUVL
$18K ﹤0.01%
209
-30
-13% -$2.37K
ALKS icon
1128
Alkermes
ALKS
$8.13B
$16K ﹤0.01%
519
-74
-12% -$2.09K
KRYS icon
1129
Krystal Biotech
KRYS
$10.7B
$16K ﹤0.01%
91
-13
-13% -$1.95K
PTCT icon
1130
PTC Therapeutics
PTCT
$6.2B
$15K ﹤0.01%
250
-5,035
-95% -$262K
VWOB icon
1131
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$15K ﹤0.01%
228
– –
ACLX
1132
DELISTED
Arcellx
ACLX
$14K ﹤0.01%
174
-24
-12% -$1.73K
AKRO
1133
DELISTED
Akero Therapeutics
AKRO
$13K ﹤0.01%
272
– –
CRNX icon
1134
Crinetics Pharmaceuticals
CRNX
$8.88B
$13K ﹤0.01%
304
– –
PTGX icon
1135
Protagonist Therapeutics
PTGX
$8.72B
$13K ﹤0.01%
190
-25
-12% -$1.42K
SEIC icon
1136
SEI Investments
SEIC
$12.5B
$13K ﹤0.01%
+151
New +$13.4K
KYMR icon
1137
Kymera Therapeutics
KYMR
$8.69B
$12K ﹤0.01%
215
-30
-12% -$1.35K
MIRM icon
1138
Mirum Pharmaceuticals
MIRM
$6.65B
$12K ﹤0.01%
158
-20
-11% -$1.27K
USHY icon
1139
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$12K ﹤0.01%
314
-14
-4% -$525
ACAD icon
1140
Acadia Pharmaceuticals
ACAD
$4.46B
$11K ﹤0.01%
530
-72
-12% -$1.7K
ADMA icon
1141
ADMA Biologics
ADMA
$2.04B
$11K ﹤0.01%
750
-108
-13% -$1.85K
LGND icon
1142
Ligand Pharmaceuticals
LGND
$5.84B
$11K ﹤0.01%
63
– –
NAMS icon
1143
NewAmsterdam Pharma
NAMS
$3.24B
$11K ﹤0.01%
375
– –
SRRK icon
1144
Scholar Rock
SRRK
$5.91B
$11K ﹤0.01%
296
-45
-13% -$1.57K
AMRX icon
1145
Amneal Pharmaceuticals
AMRX
$6.07B
$10K ﹤0.01%
1,023
– –
APLS
1146
DELISTED
Apellis Pharmaceuticals
APLS
$10K ﹤0.01%
429
– –
CAMT icon
1147
Camtek
CAMT
$6.02B
$10K ﹤0.01%
+99
New +$8.87K
XENE icon
1148
Xenon Pharmaceuticals
XENE
$6.18B
$10K ﹤0.01%
252
– –
CGON icon
1149
CG Oncology
CGON
$6.03B
$9K ﹤0.01%
234
-40
-15% -$1.16K
IMVT icon
1150
Immunovant
IMVT
$7.78B
$9K ﹤0.01%
581
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2025 Portfolio in Review

As of Q3 2025, Daiwa Securities Group held 1,385 positions worth $29.6B, up 9.4% from $27.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q3 2025 filing shows 83 new, 652 increased, 368 reduced and 52 closed positions. Its largest new stake was Eagle Materials: 54,795 shares worth $12.8M. The largest sale was Global X Conscious Companies ETF, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Real Estate and Communication Services.

  • Daiwa Securities Group's largest Q3 2025 buy was Eagle Materials: 54,795 shares worth $12.8M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2025, an estimated $163M increase.
  • Daiwa Securities Group's biggest Q3 2025 reduction was Global X Conscious Companies ETF, cutting an estimated $130M.
  • Daiwa Securities Group fully exited Ansys in Q3 2025, selling an estimated $6.94M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $29.6B portfolio in Q3 2025.
  • Daiwa Securities Group opened 83 new positions and closed 52 in Q3 2025.
  • Daiwa Securities Group's portfolio value rose 9.4% quarter-over-quarter to $29.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.